Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Eupraxia Doses First Patient in Phase 2b Placebo-Controlled RESOLVE Trial for Eosinophilic Esophagitis, Targeting Pivotal Study Readiness by Q3 2026

Author: Benzinga Newsdesk | July 08, 2025 06:05am

Posted In: EPRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist